**Question:** True about propranolol is ?

A. It is a selective alpha-1 adrenergic receptor antagonist
B. It is a selective beta-1 adrenergic receptor antagonist
C. It is a selective beta-2 adrenergic receptor agonist
D. It is a peripheral benzodiazepine receptor agonist

**Correct Answer:** B. It is a selective beta-1 adrenergic receptor antagonist

**Core Concept:** Propranolol is a beta-blocker, a class of medications that bind to beta-adrenergic receptors and block the effects of catecholamines. There are three main types of beta-adrenergic receptors: beta-1, beta-2, and beta-3. Propranolol is a selective beta-1 adrenergic receptor antagonist, meaning it primarily binds to and blocks the effects of beta-1 receptors.

**Why the Correct Answer is Right:** Propranolol's selectivity lies in its interaction with beta-1 adrenergic receptors and blocking their function. Beta-1 receptors are predominantly found in the heart, where they play a key role in regulating heart rate and contractility. By blocking these receptors, propranolol can reduce heart rate, decrease myocardial oxygen demand, and lower blood pressure, making it useful in treating conditions such as hypertension, angina pectoris, and arrhythmias.

**Why Each Wrong Option is Incorrect:**

A. Selective alpha-1 adrenergic receptor antagonists are medications like prazosin, which primarily block alpha-1 receptors found in the vasculature and bladder to treat hypertension and benign prostatic hyperplasia, respectively. Propranolol is a beta-blocker, not an alpha-1 antagonist.

C. Beta-2 receptors are primarily found in the lungs, where they play a role in bronchodilation and are essential for the relaxation of bronchial smooth muscles. Propranolol is a beta-blocker, not a selective beta-2 agonist.

D. Benzodiazepines like diazepam act as agonists at the benzodiazepine receptor, producing anxiolytic, sedative, muscle relaxant, and anticonvulsant effects. Propranolol is a beta-blocker, not a peripheral benzodiazepine receptor agonist.

**Clinical Pearl:** Propranolol is a non-selective beta-blocker, meaning it inhibits both beta-1 and beta-2 receptors. Its clinical use includes treating hypertension, angina pectoris, arrhythmias, and migraines, as it can reduce heart rate and contractility, lower blood pressure, and inhibit bronchoconstriction. However, its non-selectivity limits its specificity and can produce unwanted side effects, such as hypotension, bradycardia, and respiratory depression.